A common concern during hemiablative focal therapy for prostate cancer is the presence of significant tumours in contralateral sides of the prostate that have been missed by biopsy. In a recent study, a combination of diffusion-weighted imaging and extended 14-core biopsy was shown to efficiently predict lobes without significant cancer. The investigators recommend routine use of this approach to select patient for hemiablative therapy.
ORIGINAL RESEARCH PAPER
Matsuoka, Y. et al. Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy Eur. Urol. doi:10.1016/j.eururo.2012.10.010
Rights and permissions
About this article
Cite this article
Combined imaging–biopsy for predicting cancer-free lobes. Nat Rev Urol 9, 667 (2012). https://doi.org/10.1038/nrurol.2012.199
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2012.199